Literature DB >> 11874226

Antipsychotic polypharmacy: squandering precious resources?

Stephen M Stahl1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11874226     DOI： 10.4088/jcp.v63n0201

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  19 in total

1.  Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia.

Authors:  Kang Sim; Alex Su; Senta Fujii; Shu-Yu Yang; Mian-Yoon Chong; Gabor S Ungvari; Tianmei Si; Eun K Chung; Hin-Yeung Tsang; Yiong H Chan; Stephan Heckers; Naotaka Shinfuku; Chay H Tan
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

2.  Safety and tolerability of antipsychotic polypharmacy.

Authors:  Juan A Gallego; Jimmi Nielsen; Marc De Hert; John M Kane; Christoph U Correll
Journal:  Expert Opin Drug Saf       Date:  2012-05-08       Impact factor: 4.250

3.  Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior.

Authors:  Christoph U Correll; Ladan Shaikh; Juan A Gallego; Jeffrey Nachbar; Vladimir Olshanskiy; Taishiro Kishimoto; John M Kane
Journal:  Schizophr Res       Date:  2011-03-21       Impact factor: 4.939

Review 4.  [Augmenting atypical antipsychotic medications with clozapin].

Authors:  M Zink; H Dressing
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 5.  Antipsychotic polypharmacy in schizophrenia: benefits and risks.

Authors:  Thomas R E Barnes; Carol Paton
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

6.  Description of long-term polypharmacy among schizophrenia outpatients.

Authors:  Jaana T Suokas; Jaana M Suvisaari; Jari Haukka; Pasi Korhonen; Jari Tiihonen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-09-25       Impact factor: 4.328

Review 7.  Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice.

Authors:  Christoph U Correll; Juan A Gallego
Journal:  Psychiatr Clin North Am       Date:  2012-07-24

8.  Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan.

Authors:  Wenyu Ye; Haya Ascher-Svanum; Jennifer A Flynn; Yuka Tanji; Michihiro Takahashi
Journal:  Clinicoecon Outcomes Res       Date:  2012-01-13

9.  Polypharmacy in psychiatry: a review.

Authors:  Sanjay Kukreja; Gurvinder Kalra; Nilesh Shah; Amresh Shrivastava
Journal:  Mens Sana Monogr       Date:  2013-01

10.  Factors that influence the prescription of antipsychotics for patients with schizophrenia in china.

Authors:  Tian-Mei Si; Liang Shu; Ke-Qing Li; Xie-He Liu; Qi-Yi Mei; Gao-Hua Wang; Pei-Shen Bai; Li-Ping Ji; Xian-Sheng Chen; Cui Ma; Jian-Guo Shi; Hong-Yan Zhang; Hong Ma; Xin Yu
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-12-31       Impact factor: 2.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.